Proteostasis Therapeutics, Inc. (PTI)


Proteostasis Therapeutics, Inc. (PTI)

$1.03 USD

0.06 (6.19%)

Updated Sep 16 4:00pm

Add PTI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

PTI Daily Price Range
PTI 52-Week Price Range

PTI Stock Chart More Charts


PTI Price/Volume Stats

Current price $1.03
Prev. close $0.97
Day low $0.97
Day high $1.10
50-day MA $0.82
200-day MA $2.13
52-week high $10.38
52-week low $0.61
Volume 511,963
Avg. volume 1,274,475
Dividend yield N/A
Market Cap 52.66M

Proteostasis Therapeutics, Inc. (PTI) Company Bio


Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused by an imbalance in the proteostasis network and characterized by defects in protein folding, trafficking, and clearance, including genetic, neurodegenerative, and retinal degenerative diseases. The company was founded in 2006 and is based in Cambridge, Massachusetts.





PTI News Stream


Event/Time News Detail
Loading, please wait...

PTI Social Stream


Loading social stream, please wait...

View Full PTI Social Stream

PTI Returns

1-mo 55.71%
3-mo -1.90%
6-mo -76.21%
1-year -54.22%
3-year -92.00%
5-year N/A
YTD -68.21%
2018 -44.43%
2017 -52.45%
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4458 seconds.